key: cord-0815055-2y2w19uq authors: Pérez-Fontalvo, Nathalie Marina; De Arco-Aragón, Mayra Alejandra; Jimenez-García, Juranis del Carmen; Lozada-Martinez, Ivan David title: Molecular and computational research in low- and middle-income countries: Development is close at hand date: 2021-08-05 journal: J Taibah Univ Med Sci DOI: 10.1016/j.jtumed.2021.06.010 sha: 68d5c39d88281b30e5d3a5a0c66534d9c8d6b72f doc_id: 815055 cord_uid: 2y2w19uq nan To the Editor: We read a recently published article by Umar et al. titled 'In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants' with great interest. Through an in-silico study, the authors investigated Q6 the inhibitory effect of bioactive components of African plants on Mpro and predicted the pharmacological and toxicological profiles of these components, observing that these phytoconstituents possessed an antiviral potential against SARS-Cov-2, even greater than hydroxychloroquine. 1 We thank Umar et al. 1 for providing such valuable evidence. However Q7 , we would like to make some comments on the relevance of supporting such studies in low-and middle-income countries, and the impact they will have on their public health priorities in the near future. Given the catastrophe that the COVID-19 pandemic has generated for public health and health systems globally, 2e4 there is an evident need to strengthen the funding and organization of biomedical research not only in highincome countries, but mainly in low-and middle-income countries, which have very high indicators of poverty, inequality, violence and burden of disease. 5, 6 In-silico studies constitute a fundamental and innovative tool in the modelling of protein Q9 and molecular structures for the design and discovery of new drugs. 1, 7 Recently, Murunga et al. 8 reviewed the Q10 published evidence on knowledge, practice, and support of translational studies in low-and middleincome countries, finding that the participation from these countries on this type of studies was almost non-existent; hence, it is necessary to strengthen institutional guidelines, incentives, funding, and training to remove the barriers to perform this type of studies. 8 The same difficulties were exposed by Ahmed et al., 9 who state that, due to barriers to access to updated state of the art, low participation in global meetings, difficulties in access to quality technologies and equipment, among others, there are currently many challenges for the development of studies in biomedicine. 9 For these reasons, observing the work and results of Umar et al. 1 generates much satisfaction and enthusiasm, since according to the requirements to perform these computational studies, it is expected that these simulations are performed almost entirely in developed countries. However, it is possible to perceive that the technological and scientific development in this group of countries is gradually being achieved. More importantly, in the current context of the COVID-19 pandemic and considering the emergence of new SARS-Cov-2 strains with unpredictable behaviour, 2,3 it is imperative that each nation study the viral genotype to determine the degree of transmissibility and aggressiveness of the most prevalent strain at the local level in a personalized manner. Additionally, these studies are indispensable for the constant evaluation of therapeutic targets for other types of infectious diseases that are endemic in regions such as Latin America and the Caribbean or Africa (Tuberculosis or Malaria), and that can provide a solution sooner than expected. 10 Although it was reported a decade ago that the strengthening of health policy and research systems was very low (4 % of the total publications on these topics came from authors from low-and middle-income countries), 6 GloPID-R has recognized that the attempt to produce theoretical knowledge, treatment research, and design diagnostic tools for the solution of COVID-19 from low-and middle-income countries has been remarkable. 11 Therefore, it is expected that a significant increase in the number of molecular, clinical, and computational studies by these countries will be observed in the coming years, and that they will become a global reference. It is necessary to reinforce knowledge and specialized support networks that allow international collaborations that facilitate the search for solutions to regional and global public health problems. It is evident that the development of these countries on the part of science is getting closer and closer. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have no conflict of interest to declare. There are no ethical or financial issues, conflicts of interests, or animal experiments related to this research. Every author contributed equally in all the parts of the research. All authors have critically reviewed and approved the final draft and are responsible for the content and similarity index of the manuscript. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 In-silico analysis of the inhibition of the SARS-CoV-2 main protease by some active compounds from selected African plants The COVID-19 pandemic: effects on lowand middle-income countries Managing COVID-19 in low-and middle-income countries The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries Increasing health policy and systems research capacity in low-and middle-income countries: results from a bibliometric analysis Trends in health policy and systems research over the past decade: still too little capacity in low-income countries Editorial: in silico methods for drug design and discovery Review of published evidence on knowledge translation capacity, practice and support among researchers and research institutions in low-and middle-income countries Challenges and strategies for biomedical researchers returning to low-and middle-income countries after training Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study COVID-19 research in low and middle income countries Molecular and computational research in low-and middle-income countries: Development is close at hand